Talphera Inc (TLPH)

Talphera Inc has seen no insider trading activity within the last three months. The most recent recorded transaction occurred on March 13, 2026, involving a planned purchase by CEO Vincent J. Angotti. Prior to this, several executives executed buy orders throughout February 2026, reflecting historical patterns of leadership participation in equity acquisition.
Ticker: TLPH Exchange: NAS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Talphera Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.5
Angotti Vincent J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned purchase
Price
311.23
Quantity 76,294 -3.1%
Value US$3,132,576
2.5
Angotti Vincent J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
189.32
Quantity 29,320 -11.1%
Value US$3,155,556
2.5
Aslam Shakil Chief Medical Officer Officer
Transaction date
Purchase
Price
228.33
Quantity 95,758 -43.2%
Value US$236,422
2.3
Dasu Badri N Chief Engineering Officer Officer
Transaction date
Purchase
Price
0.81
Quantity 35,000 +84.9%
Value US$28,430
2.9
ASADORIAN RAFFI Chief Financial Officer Officer
Transaction date
Purchase
Price
0.81
Quantity 45,000 +97.3%
Value US$36,554
2.5
Angotti Vincent J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
0.59
Quantity 213,310 +112.0%
Value US$125,000
2.5
Angotti Vincent J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
0.64
Quantity 5,000 +2.5%
Value US$3,200
2.9
ASADORIAN RAFFI Officer Officer
Transaction date
Proposed sale
Price
0.69
Quantity 155
Value US$107
2.9
ASADORIAN RAFFI Chief Financial Officer Officer
Transaction date
Sale
Price
0.77
Quantity 155 -0.4%
Value US$119
2.5
Angotti Vincent J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
0.73
Quantity 5,000 +2.5%
Value US$3,650
2.5
Angotti Vincent J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned purchase
Price
1.05
Quantity 7,260 +3.8%
Value US$7,598
2.5
Aslam Shakil Chief Medical Officer Officer
Transaction date
Purchase
Price
1.07
Quantity 5,000 +15.3%
Value US$5,357
2.5
Angotti Vincent J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
1.08
Quantity 1,304 +0.7%
Value US$1,404
2.5
Aslam Shakil Chief Medical Officer Officer
Transaction date
Purchase
Price
0.98
Quantity 695 +2.2%
Value US$681
2.5
Angotti Vincent J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
0.97
Quantity 4,570 +2.6%
Value US$4,438
2.5
Angotti Vincent J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
0.97
Quantity 4,126 +2.4%
Value US$4,013
2.5
Angotti Vincent J. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.73
Quantity 10,000 +10.9%
Value US$7,268
2.5
Angotti Vincent J. Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
0.80
Quantity 10,000 +12.2%
Value US$7,950
Palmer Pamela P Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
1.09
Quantity 7,442 -19.5%
Value US$8,104
Palmer Pamela P Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
1.17
Quantity 9,514 -19.9%
Value US$11,131
Palmer Pamela P Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.17
Quantity 9,514
Value US$11,178
2.5
Angotti Vincent J. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.22
Quantity 46,400 +4.8%
Value US$10,333
2.5
Angotti Vincent J. Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
1.33
Quantity 7,547 +1.6%
Value US$10,035
EDWARDS MARK G Non-Executive Director
Transaction date
Purchase
Price
1.78
Quantity 25,000 +11.4%
Value US$44,575
Angotti Vincent J. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.79
Quantity 8,379 +3.1%
Value US$14,973
EDWARDS MARK G Non-Executive Director
Transaction date
Purchase
Price
2.17
Quantity 5,000 +2.3%
Value US$10,850
EDWARDS MARK G Non-Executive Director
Transaction date
Purchase
Price
2.20
Quantity 10,000 +4.9%
Value US$21,956
2.5
Angotti Vincent J. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.31
Quantity 5,000 +1.9%
Value US$11,550
Transaction date
Purchase
Price
2.99
Quantity 19,000 +10.5%
Value US$56,890
Palmer Pamela P Chief Medical Officer Executive Director
Transaction date
Planned purchase
Price
2.81
Quantity 840 +0.2%
Value US$2,360
Hamel Lawrence G Chief Development Officer
Transaction date
Planned purchase
Price
2.81
Quantity 3,682 +5.0%
Value US$10,346
2.9
ASADORIAN RAFFI Chief Financial Officer
Transaction date
Planned purchase
Price
2.81
Quantity 3,647 +3.0%
Value US$10,248
2.5
Angotti Vincent J. Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
2.81
Quantity 3,234 +1.3%
Value US$9,088
2.3
Dasu Badri N Chief Engineering Officer
Transaction date
Planned purchase
Price
2.81
Quantity 9,206 +8.8%
Value US$25,869
ASADORIAN RAFFI Chief Financial Officer Officer
Transaction date
Purchase
Price
2.78
Quantity 5,000 +10.6%
Value US$13,883
Angotti Vincent J. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.78
Quantity 3,610 +7.1%
Value US$10,024
Angotti Vincent J. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.99
Quantity 10,000 +24.4%
Value US$29,890
Palmer Pamela P Chief Medical Officer Executive Director
Transaction date
Purchase
Price
3.07
Quantity 16,000 +3.5%
Value US$49,120
EDWARDS MARK G Non-Executive Director
Transaction date
Purchase
Price
2.82
Quantity 20,700 +12.9%
Value US$58,376
ASADORIAN RAFFI Chief Financial Officer Officer
Transaction date
Purchase
Price
3.13
Quantity 5,000 +11.9%
Value US$15,646
Hamel Lawrence G Chief Development Officer Officer
Transaction date
Planned sale
Price
5.00
Quantity 5,216 -14.9%
Value US$26,080
Dasu Badri N Chief Engineering Officer Officer
Transaction date
Planned sale
Price
5.00
Quantity 28,351 -34.4%
Value US$141,755
Hamel Lawrence G Chief Development Officer Officer
Transaction date
Planned sale
Price
4.50
Quantity 6,953 -16.6%
Value US$31,288
EDWARDS MARK G Non-Executive Director
Transaction date
Purchase
Price
2.84
Quantity 5,300 +3.4%
Value US$15,063
Angotti Vincent J. Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
2.90
Quantity 10,000 +40.0%
Value US$28,950
ASADORIAN RAFFI Chief Financial Officer Officer
Transaction date
Purchase
Price
2.75
Quantity 5,000 +18.5%
Value US$13,725
Palmer Pamela P Chief Medical Officer Officer
Transaction date
Planned purchase
Price
2.75
Quantity 37,000 +8.8%
Value US$101,750
EDWARDS MARK G
Transaction date
Purchase
Price
3.35
Quantity 4,700 +3.1%
Value US$15,745
EDWARDS MARK G
Transaction date
Purchase
Price
3.30
Quantity 300 +0.2%
Value US$990
ASADORIAN RAFFI Chief Financial Officer Officer
Transaction date
Planned purchase
Price
3.18
Quantity 5,000 +22.7%
Value US$15,922
EDWARDS MARK G
Transaction date
Purchase
Price
1.90
Quantity 30,000 +25.0%
Value US$56,970
ASADORIAN RAFFI Chief Financial Officer
Transaction date
Purchase
Price
1.94
Quantity 5,000 +71.4%
Value US$9,710
Hamel Lawrence G Chief Development Officer
Transaction date
Planned sale
Price
5.29
Quantity 10,161 -19.5%
Value US$53,752
Hamel Lawrence G Chief Development Officer
Transaction date
Planned sale
Price
0.00
Quantity 13,827
Value US$0
ASADORIAN RAFFI Chief Financial Officer
Transaction date
Purchase
Price
3.24
Quantity 7,000 New position
Value US$22,705
EDWARDS MARK G
Transaction date
Purchase
Price
3.03
Quantity 4,800 +4.2%
Value US$14,520
Angotti Vincent J. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.00
Quantity 15,000 New position
Value US$45,000
EDWARDS MARK G
Transaction date
Purchase
Price
2.90
Quantity 200 +0.2%
Value US$580
Palmer Pamela P Chief Medical Officer Executive Director
Transaction date
Planned purchase
Price
2.95
Quantity 10,000 +2.5%
Value US$29,487
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
2.40
Quantity 875,000 -16.2%
Value US$2,100,000
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
3.88
Quantity 97,200 -1.8%
Value US$377,117
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
3.96
Quantity 119,300 -2.1%
Value US$472,380
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
3.63
Quantity 115,923 -2.0%
Value US$420,511
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
3.73
Quantity 276,927 -4.6%
Value US$1,032,301
Rosen Howard B CEO Executive Director
Transaction date
Purchase
Price
3.26
Quantity 10,206 +25.6%
Value US$33,272
EDWARDS MARK G Non-Executive Director
Transaction date
Purchase
Price
3.05
Quantity 5,000 +4.5%
Value US$15,250
EDWARDS MARK G Non-Executive Director
Transaction date
Purchase
Price
3.15
Quantity 5,000 +4.8%
Value US$15,750
EDWARDS MARK G Non-Executive Director
Transaction date
Purchase
Price
3.25
Quantity 5,000 +5.0%
Value US$16,250
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
5.35
Quantity 42,300 -0.7%
Value US$226,132
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
5.36
Quantity 133,900 -2.2%
Value US$717,409
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
4.47
Quantity 17,100 -0.3%
Value US$76,365
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
4.62
Quantity 75,000 -1.2%
Value US$346,260
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
4.18
Quantity 310,000 -4.7%
Value US$1,294,777
EDWARDS MARK G Non-Executive Director
Transaction date
Purchase
Price
3.13
Quantity 40,000 +66.7%
Value US$125,116
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-25 2026-03-13 PP Planned purchase

CHIEF EXECUTIVE OFFICER

Executive Director
76,294 -3.1%
311.23
US$3,132,576
76,294 -3.1% 311.23 US$3,132,576
2026-02-20 2026-02-12 B Purchase

CHIEF EXECUTIVE OFFICER

Executive Director
29,320 -11.1%
189.32
US$3,155,556
29,320 -11.1% 189.32 US$3,155,556
2026-02-20 2026-02-12 B Purchase

Chief Medical Officer

Officer
95,758 -43.2%
228.33
US$236,422
95,758 -43.2% 228.33 US$236,422
2026-02-20 2026-02-12 B Purchase

Chief Engineering Officer

Officer
35,000 +84.9%
0.81
US$28,430
35,000 +84.9% 0.81 US$28,430
2026-02-20 2026-02-12 B Purchase

Chief Financial Officer

Officer
45,000 +97.3%
0.81
US$36,554
45,000 +97.3% 0.81 US$36,554
2025-04-03 2025-04-02 B Purchase

CHIEF EXECUTIVE OFFICER

Executive Director
213,310 +112.0%
0.59
US$125,000
213,310 +112.0% 0.59 US$125,000
2024-12-06 2024-12-05 B Purchase

CHIEF EXECUTIVE OFFICER

Executive Director
5,000 +2.5%
0.64
US$3,200
5,000 +2.5% 0.64 US$3,200
2024-12-02 2024-12-02 PrS Proposed sale

Officer

Officer
155
0.69
US$107
155 0.69 US$107
2024-12-02 2024-12-02 S Sale

Chief Financial Officer

Officer
155 -0.4%
0.77
US$119
155 -0.4% 0.77 US$119
2024-12-02 2024-11-27 B Purchase

CHIEF EXECUTIVE OFFICER

Executive Director
5,000 +2.5%
0.73
US$3,650
5,000 +2.5% 0.73 US$3,650
2024-09-03 2024-08-30 PP Planned purchase

CHIEF EXECUTIVE OFFICER

Executive Director
7,260 +3.8%
1.05
US$7,598
7,260 +3.8% 1.05 US$7,598
2025-02-26 2024-06-14 B Purchase

Chief Medical Officer

Officer
5,000 +15.3%
1.07
US$5,357
5,000 +15.3% 1.07 US$5,357
2024-06-14 2024-06-14 B Purchase

CHIEF EXECUTIVE OFFICER

Executive Director
1,304 +0.7%
1.08
US$1,404
1,304 +0.7% 1.08 US$1,404
2025-02-26 2024-06-13 B Purchase

Chief Medical Officer

Officer
695 +2.2%
0.98
US$681
695 +2.2% 0.98 US$681
2024-06-14 2024-06-13 B Purchase

CHIEF EXECUTIVE OFFICER

Executive Director
4,570 +2.6%
0.97
US$4,438
4,570 +2.6% 0.97 US$4,438
2024-06-14 2024-06-12 B Purchase

CHIEF EXECUTIVE OFFICER

Executive Director
4,126 +2.4%
0.97
US$4,013
4,126 +2.4% 0.97 US$4,013
2023-12-14 2023-12-13 B Purchase

Chief Executive Officer

Executive Director
10,000 +10.9%
0.73
US$7,268
10,000 +10.9% 0.73 US$7,268
2023-09-11 2023-09-11 PP Planned purchase

Chief Executive Officer

Executive Director
10,000 +12.2%
0.80
US$7,950
10,000 +12.2% 0.80 US$7,950
2023-08-25 2023-08-25 PrS Proposed sale

Officer

Officer
7,450
1.10
US$8,195
7,450 1.10 US$8,195
2023-08-25 2023-08-25 PlS Planned sale

Chief Medical Officer

Executive Director
7,442 -19.5%
1.09
US$8,104
7,442 -19.5% 1.09 US$8,104
2023-08-25 2023-08-24 PlS Planned sale

Chief Medical Officer

Executive Director
9,514 -19.9%
1.17
US$11,131
9,514 -19.9% 1.17 US$11,131
2023-08-24 2023-08-24 PrS Proposed sale

Officer; Director

Executive Director
9,514
1.17
US$11,178
9,514 1.17 US$11,178
2022-06-08 2022-06-07 B Purchase

Chief Executive Officer

Executive Director
46,400 +4.8%
0.22
US$10,333
46,400 +4.8% 0.22 US$10,333
2020-06-15 2020-06-15 PP Planned purchase

Chief Executive Officer

Executive Director
7,547 +1.6%
1.33
US$10,035
7,547 +1.6% 1.33 US$10,035
2019-11-12 2019-11-12 B Purchase EDWARDS MARK G Non-Executive Director
25,000 +11.4%
1.78
US$44,575
25,000 +11.4% 1.78 US$44,575
2019-11-12 2019-11-11 B Purchase Angotti Vincent J.

Chief Executive Officer

Executive Director
8,379 +3.1%
1.79
US$14,973
8,379 +3.1% 1.79 US$14,973
2019-08-26 2019-08-26 B Purchase EDWARDS MARK G Non-Executive Director
5,000 +2.3%
2.17
US$10,850
5,000 +2.3% 2.17 US$10,850
2019-08-26 2019-08-23 B Purchase EDWARDS MARK G Non-Executive Director
10,000 +4.9%
2.20
US$21,956
10,000 +4.9% 2.20 US$21,956
2019-06-06 2019-06-05 B Purchase

Chief Executive Officer

Executive Director
5,000 +1.9%
2.31
US$11,550
5,000 +1.9% 2.31 US$11,550
2019-03-12 2019-03-12 B Purchase
19,000 +10.5%
2.99
US$56,890
19,000 +10.5% 2.99 US$56,890
2019-03-04 2019-02-28 PP Planned purchase

Chief Medical Officer

Executive Director
840 +0.2%
2.81
US$2,360
840 +0.2% 2.81 US$2,360
2019-03-04 2019-02-28 PP Planned purchase

Chief Development Officer

3,682 +5.0%
2.81
US$10,346
3,682 +5.0% 2.81 US$10,346
2019-03-04 2019-02-28 PP Planned purchase

Chief Financial Officer

3,647 +3.0%
2.81
US$10,248
3,647 +3.0% 2.81 US$10,248
2019-03-04 2019-02-28 PP Planned purchase

Chief Executive Officer

Executive Director
3,234 +1.3%
2.81
US$9,088
3,234 +1.3% 2.81 US$9,088
2019-03-04 2019-02-28 PP Planned purchase

Chief Engineering Officer

9,206 +8.8%
2.81
US$25,869
9,206 +8.8% 2.81 US$25,869
2018-12-17 2018-12-14 B Purchase ASADORIAN RAFFI

Chief Financial Officer

Officer
5,000 +10.6%
2.78
US$13,883
5,000 +10.6% 2.78 US$13,883
2018-12-17 2018-12-14 B Purchase Angotti Vincent J.

Chief Executive Officer

Executive Director
3,610 +7.1%
2.78
US$10,024
3,610 +7.1% 2.78 US$10,024
2018-12-12 2018-12-12 B Purchase Angotti Vincent J.

Chief Executive Officer

Executive Director
10,000 +24.4%
2.99
US$29,890
10,000 +24.4% 2.99 US$29,890
2018-11-19 2018-11-19 B Purchase Palmer Pamela P

Chief Medical Officer

Executive Director
16,000 +3.5%
3.07
US$49,120
16,000 +3.5% 3.07 US$49,120
2018-11-15 2018-11-15 B Purchase EDWARDS MARK G Non-Executive Director
20,700 +12.9%
2.82
US$58,376
20,700 +12.9% 2.82 US$58,376
2018-11-13 2018-11-13 B Purchase ASADORIAN RAFFI

Chief Financial Officer

Officer
5,000 +11.9%
3.13
US$15,646
5,000 +11.9% 3.13 US$15,646
2018-10-16 2018-10-15 PlS Planned sale Hamel Lawrence G

Chief Development Officer

Officer
5,216 -14.9%
5.00
US$26,080
5,216 -14.9% 5.00 US$26,080
2018-10-16 2018-10-15 PlS Planned sale Dasu Badri N

Chief Engineering Officer

Officer
28,351 -34.4%
5.00
US$141,755
28,351 -34.4% 5.00 US$141,755
2018-09-26 2018-09-24 PlS Planned sale Hamel Lawrence G

Chief Development Officer

Officer
6,953 -16.6%
4.50
US$31,288
6,953 -16.6% 4.50 US$31,288
2018-08-08 2018-08-07 B Purchase EDWARDS MARK G Non-Executive Director
5,300 +3.4%
2.84
US$15,063
5,300 +3.4% 2.84 US$15,063
2018-08-07 2018-08-07 PP Planned purchase Angotti Vincent J.

Chief Executive Officer

Executive Director
10,000 +40.0%
2.90
US$28,950
10,000 +40.0% 2.90 US$28,950
2018-08-06 2018-08-06 B Purchase ASADORIAN RAFFI

Chief Financial Officer

Officer
5,000 +18.5%
2.75
US$13,725
5,000 +18.5% 2.75 US$13,725
2018-08-06 2018-08-06 PP Planned purchase Palmer Pamela P

Chief Medical Officer

Officer
37,000 +8.8%
2.75
US$101,750
37,000 +8.8% 2.75 US$101,750
2018-06-05 2018-06-05 B Purchase EDWARDS MARK G
4,700 +3.1%
3.35
US$15,745
4,700 +3.1% 3.35 US$15,745
2018-06-05 2018-06-01 B Purchase EDWARDS MARK G
300 +0.2%
3.30
US$990
300 +0.2% 3.30 US$990
2018-05-29 2018-05-25 PP Planned purchase ASADORIAN RAFFI

Chief Financial Officer

Officer
5,000 +22.7%
3.18
US$15,922
5,000 +22.7% 3.18 US$15,922
2017-11-15 2017-11-14 B Purchase EDWARDS MARK G
30,000 +25.0%
1.90
US$56,970
30,000 +25.0% 1.90 US$56,970
2017-11-14 2017-11-13 B Purchase ASADORIAN RAFFI

Chief Financial Officer

5,000 +71.4%
1.94
US$9,710
5,000 +71.4% 1.94 US$9,710
2017-10-03 2017-10-02 PlS Planned sale Hamel Lawrence G

Chief Development Officer

10,161 -19.5%
5.29
US$53,752
10,161 -19.5% 5.29 US$53,752
2017-09-27 2017-09-25 PlS Planned sale Hamel Lawrence G

Chief Development Officer

13,827
0.00
US$0
13,827 0.00 US$0
2017-09-11 2017-09-11 B Purchase ASADORIAN RAFFI

Chief Financial Officer

7,000 New position
3.24
US$22,705
7,000 New position 3.24 US$22,705
2017-08-24 2017-08-24 B Purchase EDWARDS MARK G
4,800 +4.2%
3.03
US$14,520
4,800 +4.2% 3.03 US$14,520
2017-08-24 2017-08-24 B Purchase Angotti Vincent J.

Chief Executive Officer

Executive Director
15,000 New position
3.00
US$45,000
15,000 New position 3.00 US$45,000
2017-08-24 2017-08-22 B Purchase EDWARDS MARK G
200 +0.2%
2.90
US$580
200 +0.2% 2.90 US$580
2017-08-22 2017-08-22 PP Planned purchase Palmer Pamela P

Chief Medical Officer

Executive Director
10,000 +2.5%
2.95
US$29,487
10,000 +2.5% 2.95 US$29,487
2017-06-21 2017-06-19 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
875,000 -16.2%
2.40
US$2,100,000
875,000 -16.2% 2.40 US$2,100,000
2016-09-30 2016-09-29 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
97,200 -1.8%
3.88
US$377,117
97,200 -1.8% 3.88 US$377,117
2016-09-30 2016-09-28 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
119,300 -2.1%
3.96
US$472,380
119,300 -2.1% 3.96 US$472,380
2016-09-16 2016-09-15 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
115,923 -2.0%
3.63
US$420,511
115,923 -2.0% 3.63 US$420,511
2016-09-16 2016-09-15 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
276,927 -4.6%
3.73
US$1,032,301
276,927 -4.6% 3.73 US$1,032,301
2016-05-16 2016-05-13 B Purchase Rosen Howard B

CEO

Executive Director
10,206 +25.6%
3.26
US$33,272
10,206 +25.6% 3.26 US$33,272
2016-05-12 2016-05-12 B Purchase EDWARDS MARK G Non-Executive Director
5,000 +4.5%
3.05
US$15,250
5,000 +4.5% 3.05 US$15,250
2016-05-12 2016-05-11 B Purchase EDWARDS MARK G Non-Executive Director
5,000 +4.8%
3.15
US$15,750
5,000 +4.8% 3.15 US$15,750
2016-05-12 2016-05-10 B Purchase EDWARDS MARK G Non-Executive Director
5,000 +5.0%
3.25
US$16,250
5,000 +5.0% 3.25 US$16,250
2015-11-19 2015-11-18 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
42,300 -0.7%
5.35
US$226,132
42,300 -0.7% 5.35 US$226,132
2015-11-19 2015-11-17 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
133,900 -2.2%
5.36
US$717,409
133,900 -2.2% 5.36 US$717,409
2015-11-09 2015-11-06 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
17,100 -0.3%
4.47
US$76,365
17,100 -0.3% 4.47 US$76,365
2015-11-09 2015-11-05 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
75,000 -1.2%
4.62
US$346,260
75,000 -1.2% 4.62 US$346,260
2015-09-11 2015-09-09 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
310,000 -4.7%
4.18
US$1,294,777
310,000 -4.7% 4.18 US$1,294,777
2015-05-07 2015-05-07 B Purchase EDWARDS MARK G Non-Executive Director
40,000 +66.7%
3.13
US$125,116
40,000 +66.7% 3.13 US$125,116

See older Talphera Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Talphera Inc history with Plus

Billed monthly · Cancel anytime